146 related articles for article (PubMed ID: 26832406)
21. Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
Nilsson LM; Keller UB; Yang C; Nilsson JA; Cleveland JL; Roussel MF
Oncogene; 2007 May; 26(20):2833-9. PubMed ID: 17099725
[TBL] [Abstract][Full Text] [Related]
22. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
[TBL] [Abstract][Full Text] [Related]
23. Bptf determines oncogenic addiction in aggressive B-cell lymphomas.
Richart L; Felipe I; Delgado P; Andrés MP; Prieto J; Pozo ND; García JF; Piris MA; Ramiro A; Real FX
Oncogene; 2020 Jun; 39(25):4884-4895. PubMed ID: 32451433
[TBL] [Abstract][Full Text] [Related]
24. Unexpected suppression of tumorigenesis by c-MYC via TFAP4-dependent restriction of stemness in B lymphocytes.
Tonc E; Takeuchi Y; Chou C; Xia Y; Holmgren M; Fujii C; Raju S; Chang GS; Iwamoto M; Egawa T
Blood; 2021 Dec; 138(24):2526-2538. PubMed ID: 34283887
[TBL] [Abstract][Full Text] [Related]
25. Id2 is dispensable for myc-induced lymphomagenesis.
Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
[TBL] [Abstract][Full Text] [Related]
26. ATMIN is a transcriptional regulator of both lung morphogenesis and ciliogenesis.
Goggolidou P; Stevens JL; Agueci F; Keynton J; Wheway G; Grimes DT; Patel SH; Hilton H; Morthorst SK; DiPaolo A; Williams DJ; Sanderson J; Khoronenkova SV; Powles-Glover N; Ermakov A; Esapa CT; Romero R; Dianov GL; Briscoe J; Johnson CA; Pedersen LB; Norris DP
Development; 2014 Oct; 141(20):3966-77. PubMed ID: 25294941
[TBL] [Abstract][Full Text] [Related]
27. Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells.
Wang P; Lushnikova T; Odvody J; Greiner TC; Jones SN; Eischen CM
Oncogene; 2008 Mar; 27(11):1590-8. PubMed ID: 17828300
[TBL] [Abstract][Full Text] [Related]
28. A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice.
Poe JC; Minard-Colin V; Kountikov EI; Haas KM; Tedder TF
J Immunol; 2012 Sep; 189(5):2318-25. PubMed ID: 22826319
[TBL] [Abstract][Full Text] [Related]
29. Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells.
Mensink M; Anstee NS; Robati M; Schenk RL; Herold MJ; Cory S; Vandenberg CJ
Cell Death Differ; 2018 Mar; 25(4):797-808. PubMed ID: 29339775
[TBL] [Abstract][Full Text] [Related]
30. MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.
Högstrand K; Grandien A
Eur J Immunol; 2019 Mar; 49(3):375-385. PubMed ID: 30281155
[TBL] [Abstract][Full Text] [Related]
31. p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.
Post SM; Quintás-Cardama A; Terzian T; Smith C; Eischen CM; Lozano G
Oncogene; 2010 Mar; 29(9):1260-9. PubMed ID: 19935700
[TBL] [Abstract][Full Text] [Related]
32. ASCIZ/ATMIN is dispensable for ATM signaling in response to replication stress.
Liu R; King A; Hoch NC; Chang C; Kelly GL; Deans AJ; Heierhorst J
DNA Repair (Amst); 2017 Sep; 57():29-34. PubMed ID: 28648892
[TBL] [Abstract][Full Text] [Related]
33. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
34. Multivalency regulates activity in an intrinsically disordered transcription factor.
Clark S; Myers JB; King A; Fiala R; Novacek J; Pearce G; Heierhorst J; Reichow SL; Barbar EJ
Elife; 2018 May; 7():. PubMed ID: 29714690
[TBL] [Abstract][Full Text] [Related]
35. IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3.
Petrenko O; Li J; Cimica V; Mena-Taboada P; Shin HY; D'Amico S; Reich NC
PLoS One; 2021; 16(3):e0247394. PubMed ID: 33651821
[TBL] [Abstract][Full Text] [Related]
36. LC8 dynein light chain (DYNLL1) binds to the C-terminal domain of ATM-interacting protein (ATMIN/ASCIZ) and regulates its subcellular localization.
Rapali P; García-Mayoral MF; Martínez-Moreno M; Tárnok K; Schlett K; Albar JP; Bruix M; Nyitray L; Rodriguez-Crespo I
Biochem Biophys Res Commun; 2011 Oct; 414(3):493-8. PubMed ID: 21971545
[TBL] [Abstract][Full Text] [Related]
37. Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival.
Nam J; Kim DU; Kim E; Kwak B; Ko MJ; Oh AY; Park BJ; Kim YW; Kim A; Sun H; Jung Y; Lee JH; Shin HJ; Park I; Song DK; Jeong JY; Lee YH; Kim SW
Leukemia; 2019 Dec; 33(12):2912-2923. PubMed ID: 31138843
[TBL] [Abstract][Full Text] [Related]
38. Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice.
Gerbitz A; Sukumar M; Helm F; Wilke A; Friese C; Fahrenwaldt C; Lehmann FM; Loddenkemper C; Kammertoens T; Mautner J; Schmitt CA; Blankenstein T; Bornkamm GW
PLoS One; 2012; 7(3):e34552. PubMed ID: 22479645
[TBL] [Abstract][Full Text] [Related]
39. Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis.
Keller UB; Old JB; Dorsey FC; Nilsson JA; Nilsson L; MacLean KH; Chung L; Yang C; Spruck C; Boyd K; Reed SI; Cleveland JL
EMBO J; 2007 May; 26(10):2562-74. PubMed ID: 17464290
[TBL] [Abstract][Full Text] [Related]
40. Dynll1 is essential for development and promotes endochondral bone formation by regulating intraflagellar dynein function in primary cilia.
King A; Hoch NC; McGregor NE; Sims NA; Smyth IM; Heierhorst J
Hum Mol Genet; 2019 Aug; 28(15):2573-2588. PubMed ID: 31009951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
